Findings of this study suggest that dynamic hs-cTnT concentrations are commonly observed in patients with AKI, limiting the clinical accuracy for MI, and highlights the need for novel hs-cTn–based approaches to increase specificity for MI among this patient population. Here, TNNT2 is linked to acute kidney injury.